2585. Prognostic value of integrated cytogenetic,
somatic variation, and copy number variation
analyses in Korean patients with newly
diagnosed multiple myeloma
2583. Talazoparib Versus Chemotherapy in Patients with HER2-negative Advanced Breast Cancer and a Germline BRCA1/2 Mutation Enrolled in Asian Countries: Exploratory Subgroup Analysis of the Phase III EMBRACA Trial
Cancer research and treatment 2021 Oct;53(4):1084-1095.Link
2582. Phase II Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiotherapy with Gemcitabine in Patients with Resected Pancreatic Cancer
Kyung-Hun Lee, Eui Kyu Chie, Seock-Ah Im, Jee Hyun Kim, Jihyun Kwon, Sae-Won Han, Do-Youn Oh, Jin-Young Jang, Jae-Sung Kim, Tae-You Kim, Yung-Jue Bang, Sun Whe Kim, Sung W Ha
Cancer research and treatment 2021 Oct;53(4):1096-1103.Link
2581. Phase II Study of Avelumab in Patients with Advanced Hepatocellular Carcinoma Previously Treated with Sorafenib
Dae-Won Lee, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Tae-Yong Kim, Sae-Won Han, Do-Youn Oh, Seock-Ah Im, Tae-You Kim, Youngeun Lee, Haeryoung Kim, Kyung-Hun Lee
Clinical cancer research 2021 Feb 1;27(3):713-718.Link
2580. Association of Insulin, Metformin, and Statin with Mortality in Breast Cancer Patients
Mihong Choi, Jiyeon Han, Bo Ram Yang, Myoung-jin Jang, Miso Kim, Dae-Won Lee, Tae-Yong Kim, Seock-Ah Im, Han-Byoel Lee, Hyeong-Gon Moon, Wonshik Han, Dong-Young Noh, Kyung-Hun Lee
Cancer research and treatment 2021 Jan;53(1):65-76.Link
2579. Radiosynthesis and characterization of [ 18 F]BS224: a next-generation TSPO PET ligand insensitive to the rs6971 polymorphism
Sang Hee Lee 1 2, Nunzio Denora 3, Valentino Laquintana 3, Giuseppe Felice Mangiatordi 4, Angela Lopedota 3, Antonio Lopalco 3, Annalisa Cutrignelli 3, Massimo Franco 3, Pietro Delre 4 5, In Ho Song 1, Hye Won Kim 1 2, Su Bin Kim 1 2, Hyun Soo Park 1, Kyungmin Kim 6 7 8, Seok-Yong Lee 6 7 8, Hyewon Youn 6 8, Byung Chul Lee 1 9, Sang Eun Kim 10 11 12
Eur J Nucl Med Mol Imaging
. 2021 Nov 16. doi: 10.1007/s00259-021-05617-4. Online ahead of print.Link
2578. Pan-RAF inhibitor LY3009120 is highly synergistic with low-dose cytarabine, but not azacitidine, in acute myeloid leukemia with RAS mutations
Jihyun Park 1 2, Hyejoo Park 1 2, Ja Min Byun 3, Junshik Hong 1 2 3, Dong-Yeop Shin 2 3, Youngil Koh 1 2 3, Sung-Soo Yoon 1 2 3
2577. Limited benefits of thalidomide and dexamethasone maintenance after autologous stem cell transplantation in newly diagnosed multiple myeloma patients: a prospective phase II multi-center study in Korea
Ja Min Byun 1, Sang-A Kim 2, Youngil Koh 1, Dong-Yeop Shin 1, Ji Hyun Kwon 3, Jin Seok Kim 4, Kihyun Kim 5, Chang-Ki Min 6, Hyeon-Seok Eom 7, Je-Jung Lee 8, Soo-Mee Bang 9, Sung-Soo Yoon 10